LAMAs Are Safe Irrespective of Cardiovascular Risk in COPD LAMAs Are Safe Irrespective of Cardiovascular Risk in COPD

Long-acting antimuscarinic antagonists are safe for patients with chronic obstructive pulmonary disease and will not increase the risk for a cardiovascular event, new data show.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news